BPC-157
Synthetic Gastric Pentadecapeptide Studied for Tissue Repair
Written by
Dr. Elena Rostova · Ph.D. Biochemistry
Medical review
Dr. Marcus Vance · PharmD, RPh
Last reviewed
August 15, 2026
About the Author
Dr. Elena Rostova · Ph.D. Biochemistry
Lead Research Scientist & Science Editor
Molecular biochemist and peptide researcher with expertise in solid-phase peptide synthesis (SPPS), HPLC purity verification, and mass spectrometry characterization. Directs literature compilation and scientific dossier synthesis at BioPeptide.
About the Reviewer
Dr. Marcus Vance · PharmD, RPh
Medical & Pharmacology Reviewer
Clinical pharmacist and pharmacokinetics consultant specializing in peptide pharmacology, receptor signaling, and preclinical safety data. Focuses on rigorous evaluation of published biochemical literature, receptor kinetics, and study methodology.
Overview
BPC-157 (Body Protection Compound-157) is a synthetic peptide composed of 15 amino acids, modeled on a protective protein fragment identified in human gastric juice. It has become one of the most widely discussed peptides in regenerative-medicine research literature, primarily studied in rodent models for its apparent influence on tissue-repair pathways.
Proposed Mechanism
Preclinical investigations propose that BPC-157 interacts with the nitric oxide signaling system and may upregulate growth-factor expression, including markers associated with angiogenesis (the formation of new blood vessels). Animal studies have examined its role in accelerating healing across gut lining, tendon, ligament, muscle, and nerve-tissue models, though the precise molecular receptor or pathway remains an active area of investigation.
Research Highlights
- Rodent studies have examined BPC-157's role in protecting and healing gastrointestinal lining, including models of induced ulcers and inflammatory bowel injury
- Animal research has explored its influence on tendon-to-bone healing and ligament repair following surgical transection models
- Laboratory studies have investigated potential anti-inflammatory and cytoprotective effects across multiple organ-injury models
Research Dosing Reference
Rodent gastrointestinal models
Commonly referenced in published gut-healing studies; scaled to animal body weight — not a human guideline
≈10 µg per kg body weight
Rodent musculoskeletal models
Range observed across tendon and muscle-repair literature; administration route and frequency vary by study design
≈1–10 µg per kg body weight
Figures above are reported ranges from published animal/laboratory studies, summarized for academic reference — not recommendations for human or animal administration.
Reported Research Cycle Lengths
Compound literature and reference guides commonly cite research cycles of roughly 4 to 8 weeks for BPC-157 in published protocols and vendor references, often grouped with other tissue-repair peptides.
Durations referenced here reflect ranges commonly cited across compound literature and reference guides — summarized for academic comparison only. They are not usage recommendations for humans or animals, and do not substitute for primary source review.
Reconstitution & Volume Calculator
A unit-conversion utility for laboratory use. It converts a vial strength and reconstitution volume into a draw volume — it performs arithmetic only and does not suggest, recommend, or imply an appropriate amount of BPC-157 for any purpose.
Concentration
2500.0 mcg/mL
Draw volume
0.100 mL
Syringe reading
10.0 units
For laboratory research reference only — not medical advice, and not a dosing recommendation for human or animal use. "Syringe reading" assumes a standard U-100 (100 units per mL) insulin syringe.
Safety & Compliance Notes
- BPC-157 is not approved by the FDA or any regulatory body for human use and has not completed human clinical trials
- All figures above are drawn from published animal-model research and are provided for academic reference only — they are not dosing instructions
- Products are sold strictly for laboratory research use — not for human consumption
Primary Research Citations
Directly indexed peer-reviewed studies supporting this compound profile
Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, et al. · Current Pharmaceutical Design (2011)
PMID: 21548867Chang CH, Tsai WC, Hsu YH, Pang JH · Journal of Applied Physiology (2011)
PMID: 21030672Seiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, et al. · Current Pharmaceutical Design (2018)
PMID: 29898937Hsieh CH, Liu HT, Wang YC, Chou YC, Chen PT, Hsu YH, et al. · Molecules (2020)
PMID: 32244465
Research Grade · >99% HPLC Verified
Order research-grade BPC-157with batch-specific Certificate of Analysis (COA). Synthesized to >99% purity. Orders are typically processed within 1–3 business days of payment confirmation.
This page is provided for educational and research-reference purposes only and does not constitute medical advice, a treatment recommendation, or an endorsement of human use. Always consult primary peer-reviewed literature and a qualified professional before drawing conclusions about any compound. All products referenced are sold strictly for laboratory research — not for human consumption.